RECCE PHARMACEUTICALS LTD — Share Issue/Capital Change 2022

Nov 14, 2022

Announcement Summary

Entity name

RECCE PHARMACEUTICALS LTD

Date of this announcement

Tuesday November 15, 2022

The +securities the subject of this notification are:

+Other securities issued under an +employee incentive scheme that are not intended to be quoted on ASX

Total number of +securities to be issued/transferred

ASX +securitycode	Security description	Total number of+securities to beissued/transferred	Issue date
RCEAU	OPTION EXPIRING VARIOUS DATES EXVARIOUS PRICES	1,125,000	15/11/2022

Refer to next page for full details of the announcement

Part 1 - Entity and announcement details

1.1 Name of entity

RECCE PHARMACEUTICALS LTD

We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities.

1.2 Registered number type

ACN

Registration number

124849065

1.3 ASX issuer code RCE

1.4 The announcement is

New announcement

1.5 Date of this announcement

15/11/2022

Part 2 - Issue details

2.1 The +securities the subject of this notification are:

+Other securities issued under an +employee incentive scheme that are not intended to be quoted on ASX

2.2a This notification is given in relation to an issue of +securities in a class which is not quoted on ASX and which:

has an existing ASX security code ("existing class")

Equity Securities

Part 3B - number and type of +securities the subject of this notification (existing class) where issue has not previously been notified to

ASX in an Appendix 3B

ASX +security code and description

RCEAU : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES

Date the +securities the subject of this notification were issued

15/11/2022

Will these +securities rank equally in all respects from their issue date with the existing issued +securities in that class Yes

Were any of the +securities issued to +key management personnel (KMP) or an +associate? Yes

Provide details of the KMP or +associates being issued +securities.

Name of KMP	Name of registered holder	Number of +securities
Alistair McKeough	Amabel Pty Limited ATF McKeoughFamily Trust	1,125,000

Please provide a URL link for a document lodged with ASX detailing the terms of the +employee incentive scheme or a summary of the terms

https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02582550-6A1115516?access\_token=8 3ff96335c2d45a094df02a206a39ff4

Any other information the entity wishes to provide about the +securities the subject of this notification

Unlisted options issued to Alistair McKeough, Director of the Company, as approved by shareholders at the AGM held on 14 November 2022.

Issue details

Equity Securities

Number of +securities 1,125,000

Part 4 - +Securities on issue

Following the issue, conversion or payment up of the +securities the subject of this application, the +securities ofthe entity will comprise:(A discrepancy in these figures compared to your own may be due to a matter of timing if there is more than oneapplication for quotation/issuance currently with ASX for processing.)
4.1 Quoted +Securities (Total number of each +class of +securities quoted)
ASX +security code and description	Total number of+securities on issue
RCE : ORDINARY FULLY PAID	178,079,310
4.2 Unquoted +Securities (Total number of each +class of +securities issued but not quoted on ASX)
ASX +security code and description	Total number of+securities on issue
RCEAH : PERFORMANCE SHARES	8,754,423
RCEAW : OPTION EXPIRING 11-FEB-2027 EX $1.56	435,000
RCEAU : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES	1,903,435

RCEAV : OPTION EXPIRING 30-SEP-2023 EX $1.56 3,750,000

RCEAN : OPTION EXPIRING 22-FEB-2026 EX $1.56 8,415,000

Equity Securities

Part 5 - Other Listing Rule requirements

5.1 Were the +securities issued under an exception in Listing Rule 7.2 and therefore the issue did not need any security holder approval under Listing Rule 7.1? Yes

5.1a Select the number of the applicable exception in Listing Rule 7.2

14